This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saurin, J.-C. Articles by Abello, J. Search for Related Content PubMed PubMed Citation Articles by Saurin, J.-C. Articles by Abello, J.

Bombesin Stimulates Invasion and Migration of Isreco1 Colon Carcinoma Cells in a Rho-dependent Manner¹

INSERM Unité 45 and IFR 62, Hôpital Edouard-Herriot, Pavillon H, F-69437 Lyon Cedex 3, France [J-C. S., M. F., J-C. G., J-A. C., J. A.] and Department of Experimental Pathology, Swiss Institute for Cancer Research (ISREC), CH-1066 Epalinges, Switzerland [B. S.]

The membrane receptor for the neuropeptide bombesin/gastrin-releasing peptide (GRP) is expressed by a large fraction of human colorectal carcinoma cells. We reported previously a stimulation of cell adhesion and lamellipodia formation by the neuropeptide bombesin in the human, bombesin/GRP receptor-expressing, Isreco1 colorectal cancer cell line (J. C. Saurin et al., Cancer Res., 59: 962–967, 1999). Using invasion and motility assays, we demonstrate in this report that bombesin can both enhance the invasive capacity of Isreco1 cells in a dose-dependent manner (maximal effect at 1 nM) and stimulate the closure of wounds performed on confluent Isreco1 cells. These effects were reversed fully by the specific bombesin/GRP receptor antagonist D-Phe⁶-Bn(6-13)OMe used at 1 µM. MMP-9 and urokinase-type plasminogen activator were expressed by Isreco1 cells, and bombesin did not significantly alter their level of secretion. Interestingly, exoenzyme C3 (10 µg/ml) decreased cell invasiveness induced by bombesin by 70% and completely inhibited the migration of Isreco1 cells. Similarly, the Rho-kinase inhibitor Y-27632 dose-dependently reduced the effect of bombesin on cell invasion. Moreover, pull-down assays for GTP-bound RhoA demonstrated that bombesin was able to activate the small G-protein in Isreco1 cells. These results show that the neuropeptide bombesin is able to modulate invasiveness of Isreco1 colorectal carcinoma cells in vitro through a Rho-dependent pathway, leading to an increase in cell locomotion without a significant effect on tumor-cell associated proteolytic activity. These findings indicate that bombesin/GRP receptor expression may contribute to the cellular events that are critical for invasion/migration of colorectal carcinoma cells.

This article has been cited by other articles:

				J. Fang, Y. Lu, K. Ouyang, G. Wu, H. Zhang, Y. Liu, Y. Chen, M. Lin, H. Wang, L. Jin, et al. Specific Antibodies Elicited by a Novel DNA Vaccine Targeting Gastrin-Releasing Peptide Inhibit Murine Melanoma Growth In Vivo Clin. Vaccine Immunol., July 1, 2009; 16(7): 1033 - 1039. [Abstract] [Full Text] [PDF]

				Y.-H. Hsieh, T.-T. Wu, C.-Y. Huang, Y.-S. Hsieh, J.-M. Hwang, and J.-Y. Liu p38 Mitogen-Activated Protein Kinase Pathway Is Involved in Protein Kinase C{alpha}-Regulated Invasion in Human Hepatocellular Carcinoma Cells Cancer Res., May 1, 2007; 67(9): 4320 - 4327. [Abstract] [Full Text] [PDF]

				A. M. Hopkins, A. A. Pineda, L. M. Winfree, G. T. Brown, M. G. Laukoetter, and A. Nusrat Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G806 - G817. [Abstract] [Full Text] [PDF]

				A. Fleischmann, B. Waser, J.-O. Gebbers, and J. C. Reubi Gastrin-Releasing Peptide Receptors in Normal and Neoplastic Human Uterus: Involvement of Multiple Tissue Compartments J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4722 - 4729. [Abstract] [Full Text] [PDF]

				S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1274 - G1282. [Abstract] [Full Text] [PDF]

				L. M. McHardy, K. Warabi, R. J. Andersen, C. D. Roskelley, and M. Roberge Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions Mol. Cancer Ther., May 1, 2005; 4(5): 772 - 778. [Abstract] [Full Text] [PDF]